Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting individual differences in peak emotional response.
Schoeller F, Christov-Moore L, Lynch C, Diot T, Reggente N. Schoeller F, et al. Among authors: lynch c. PNAS Nexus. 2024 Mar 5;3(3):pgae066. doi: 10.1093/pnasnexus/pgae066. eCollection 2024 Mar. PNAS Nexus. 2024. PMID: 38444601 Free PMC article.
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, Felton TW, Ghuman BK, Gordon AC, Hellyer TP, Lone NI, Manazar U, Richards G, McCullagh IJ, McMullan R, McNamee JJ, McNeil HC, Mouncey PR, Naisbitt MJ, Parker RJ, Poole RL, Rostron AJ, Singer M, Stevenson MD, Walsh TS, Welters ID, Whitehouse T, Whiteley S, Wilson P, Young KK, Perkins GD, Lall R; ADAPT-Sepsis Collaborators. Dark P, et al. JAMA. 2024 Dec 9. doi: 10.1001/jama.2024.26458. Online ahead of print. JAMA. 2024. PMID: 39652885
Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma.
Bishop RT, Li T, Sudalagunta P, Nasr M, Nyman KJ, Alugubelli RR, Meads M, Frieling J, Nerlakanti N, Tauro M, Fang B, Grant S, Koomen J, Silva AS, Shain KH, Lynch CC. Bishop RT, et al. Among authors: lynch cc. Haematologica. 2024 Dec 5. doi: 10.3324/haematol.2024.285587. Online ahead of print. Haematologica. 2024. PMID: 39633543 Free article.
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ.
Debeljak M, Cho S, Downs BM, Considine M, Avin-McKelvey B, Wang Y, Perez PN, Grizzle WE, Hoadley KA, Lynch CF, Hernandez BY, van Diest PJ, Cozen W, Hamilton AS, Hawes D, Gabrielson E, Cimino-Mathews A, Florea LD, Cope L, Umbricht CB. Debeljak M, et al. Among authors: lynch cf. Breast Cancer Res. 2024 Dec 4;26(1):178. doi: 10.1186/s13058-024-01927-1. Breast Cancer Res. 2024. PMID: 39633428 Free PMC article.
Antiviral target compound profile for pandemic preparedness.
Demarest JF, Draghia-Akli R, Cihlar T, Bradley K, Young JAT, Chandra R, Vaidyanathan S, Chu-Moyer M, Lynch CL, Campbell A, Saikatendu KS, Bilello JP, Murata Y, van Loock M, Hurt AC, Tellinghuisen T, Ruggiero L, Mackman R, Hill NM, Pottage JC Jr; INTREPID Alliance. Demarest JF, et al. Among authors: lynch cl. Nat Rev Drug Discov. 2024 Dec 2. doi: 10.1038/s41573-024-01102-3. Online ahead of print. Nat Rev Drug Discov. 2024. PMID: 39622985 No abstract available.
2,227 results